Concepedia
Statistics
Publications
22
Citations
5.2K
H-Index
16
Active since
1980
Affiliations
Quality Research(Current)
Texas Liver Institute
The University of Texas at San Antonio Health Science Center
Gilead Sciences (United States)
Scripps Clinic
Robert Herring is an author at Quality Research specializing in pharmacotherapy, antiviral therapy, and viral hepatitis.
Publications per year
1980–2022
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations
Medicine, Infectious Diseases, Microbiology +12
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text
Medicine, Internal Medicine, Pharmacology +8
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +13
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 321 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 22